Effect of Long-Detection Interval vs Standard-Detection Interval for Implantable Cardioverter-Defibrillators on Antitachycardia Pacing and Shock Delivery: The ADVANCE III Randomized Clinical Trial

• Published in: JAMA : the journal of the American Medical Association 2013-05, Vol.309 (18), p.1903-1911
• Main Authors: Gasparini, Maurizio, Proclemer, Alessandro, Klersy, Catherine, Kloppe, Axel, Lunati, Maurizio, Ferrer, José Bautista Martìnez, Hersi, Ahmad, Gulaj, Marcin, Wijfels, Maurits C. E. F, Santi, Elisabetta, Manotta, Laura, Arenal, Angel
• Format: Article
• Language: English
• Subjects: Aged; Algorithms; Arrhythmias, Cardiac - diagnosis; Arrhythmias, Cardiac - mortality; Arrhythmias, Cardiac - therapy; Biological and medical sciences; Cardiac Pacing, Artificial; Cardiology; Defibrillators; Defibrillators, Implantable - adverse effects; Delivery. Postpartum. Lactation; Electric Countershock - methods; Female; General aspects; Gynecology. Andrology. Obstetrics; Heart surgery; Hospitalization - statistics & numerical data; Humans; Male; Medical sciences; Middle Aged; Myocardial Ischemia - complications; Primary Prevention; Quality of Life; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects); Secondary Prevention; Single-Blind Method; Surgical outcomes; Time Factors; Transplants & implants; Treatment Outcome
• ISSN: 0098-7484; 1538-3598
• DOI: 10.1001/jama.2013.4598

IMPORTANCE Using more intervals to detect ventricular tachyarrhythmias has been associated with reducing unnecessary implantable cardioverter-defibrillator (ICD) therapies. OBJECTIVE To determine whether using 30 of 40 intervals to detect ventricular arrhythmias (VT) (long detection) during spontaneous fast VT episodes reduces antitachycardia pacing (ATP) and shock delivery more than 18 of 24 intervals (standard detection). DESIGN, SETTING, AND PARTICIPANTS Randomized, single-blind, parallel-group trial that enrolled 1902 primary and secondary prevention patients (mean [SD] age, 65 [11] years; 84% men; 75% primary prevention ICD) with ischemic and nonischemic etiology undergoing first ICD implant at 1 of 94 international centers (March 2008-December 2010). INTERVENTIONS Patients were randomized 1:1 to programming with long- (n = 948) or standard-detection (n = 954) intervals. MAIN OUTCOMES AND MEASURES Total number of ATPs and shocks delivered for all episodes (primary outcomes) and inappropriate shocks, mortality, and syncopal rate (secondary outcomes). RESULTS During a median follow-up of 12 months (interquartile range, 11-13), long-detection group had 346 delivered therapies (42 therapies per 100 person-years, 95% CI, 38-47) vs 557 in the standard-detection group (67 therapies per 100 person-years [95% CI, 62-73]; incident rate ratio [IRR], 0.63 [95% CI, 0.51-0.78]; P